TDAC - NASDAQ

Translational Development Acquisition Corp.

TDAC·NASDAQ

$10.74

-0.19%

Financial ServicesShell Companies

Translational Development Acquisition Corp. does not have significant operations. It intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Translational Development Acquisition Corp. was incorporated in 2022 and is based in New York, New York.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$235.29M

EPS0.3700

P/E Ratio29.03

Earnings Date05/15/2026

181.70M

Assets

3Y+41456.0%

5Y+41456.0%

10Y+41456.0%

6.58M

Total Liabilities

3Y+1333.0%

5Y+1333.0%

10Y+1333.0%

175.12M

Total Equity

3Y-792190.0%

5Y-792190.0%

10Y-792190.0%

Translational Development Acquisition Corp. Funding & Solvency Profile

TDAC · NASDAQ

Current Assets

Cash & Cash Equivalents29.79K

Net Receivables0.00

Inventory0.00

Other Current Assets0.00

Total Current Assets39 K

Non-Current Assets

Property, Plant & Equipment0.00

Goodwill & Intangible Assets0.00

Long-Term Investments181.66M

Other Non-Current Assets0.00

Total Non-Current Assets182 M

Total Assets

181.70M

Financial Health Analysis

Current Ratio

0.07x

Warning: Liquidity concerns. Current assets may not be sufficient to cover short-term obligations.

Debt-to-Equity Ratio

0.04x

Conservative capital structure. The company relies primarily on equity financing, indicating low financial risk.

Working Capital

-504608

Negative working capital indicates short-term liabilities exceed short-term assets—potential liquidity stress.

Asset Composition

0% Current

Capital-intensive business with significant long-term investments in property, equipment, or intangibles.

Financial Health Insight

Conservative with tight liquidity: Low debt is positive, but current ratio warrants attention. Consider whether the company is efficiently deploying its equity capital.

Translational Development Acquisition Corp. Balance Sheet

TDAC • NASDAQ

Translational Development Acquisition Corp. Balance Sheet	Dec 2025	Dec 2024	Dec 2023	Dec 2022
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	29.8K	438.2K	2K	2.2K
Cash & Short-Term Investments	29.8K	438.2K	2K	2.2K
Prepaids	9.7K	212.1K	0.0	52K
Total Current Assets	39.5K	650.2K	2K	54.2K
NON-CURRENT ASSETS
Goodwill	0.0	9,061.7B	0.0	0.0
Intangible Assets	0.0	12,569.2B	0.0	0.0
Goodwill & Intangible Assets	0.0	21,630.8B	0.0	0.0
Long-Term Investments	181.7M	174.4M	0.0	0.0
Other Non-Current Assets	0.0	-21,630.8B	0.0	383K
Total Non-Current Assets	181.7M	174.4M	0.0	383K
Total Assets	181.7M	175M	2K	437.2K
LIABILITIES
CURRENT LIABILITIES
Total Payables	0.0	18.2K	1.3K	0.0
Accounts Payable	0.0	16.2K	1.3K	0.0
Other Payables	0.0	2K	0.0	0.0
Accrued Expenses	0.0	192.1K	162.2K	200.4K
Short Term Debt	200K	6,110.8B	347.5K	259K
Other Current Liabilities	344.1K	-6,110.8B	-1.3K	0.0
Total Current Liabilities	544.1K	210.3K	509.7K	459.4K
NON-CURRENT LIABILITIES
Other Non-Current Liabilities	6M	6M	0.0	0.0
Total Non-Current Liabilities	6M	6M	0.0	0.0
Total Liabilities	6.6M	6.2M	509.7K	459.3K
SHAREHOLDERS' EQUITY
Common Stock	181.7M	18.3B	466.0	466.0
Additional Paid-In Capital	0.0	0.0	24.5K	24.5K
Retained Earnings	-6.5M	-5.6M	-532.7K	-47.1K
Accumulated Other Comprehensive Income/Loss	0.0	16.9B	0.0	0.0
Other Total Stockholders' Equity	0.0	-35B	0.0	0.0
Total Stockholders' Equity	175.1M	168.8M	-507.7K	-22.1K
Total Equity	175.1M	168.8M	-507.7K	-22.1K
SUMMARY
Total Liabilities & Equity	181.7M	175M	2K	437.2K
Total Investments	181.7M	174.4M	0.0	0.0
Total Debt	200K	6,110.8B	347.5K	259K
Net Debt	170.2K	-438.2K	345.5K	256.8K
Shares Outstanding	21,907,500	21,907,500	21,907,500	21,907,500

SEC Filings

TDAC - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
8-K 8-K 2026 N/A	May 22, 2026	May 21, 2026	2026	View Filing
8-K/A 8-K/A 2026 (Amended) N/A	May 05, 2026	February 17, 2026	2026	View Filing
8-K 8-K 2026 N/A	April 28, 2026	April 27, 2026	2026	View Filing
8-K 8-K 2026 N/A	April 23, 2026	April 17, 2026	2026	View Filing
8-K 8-K 2026 N/A	March 18, 2026	March 16, 2026	2026	View Filing
8-K 8-K 2026 N/A	March 02, 2026	February 25, 2026	2026	View Filing
8-K 8-K 2026 N/A	February 23, 2026	February 17, 2026	2026	View Filing
8-K 8-K 2026 N/A	February 19, 2026	February 18, 2026	2026	View Filing
8-K 8-K 2026 N/A	February 10, 2026	February 09, 2026	2026	View Filing
8-K 8-K 2026 N/A	February 02, 2026	January 26, 2026	2026	View Filing

Showing 1 to 10 of 211 filings

Related Guides

Blog Categories

Continue your TDAC research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.